Related Practice Areas

Practice Contacts


Print PDF

Pharmaceutical Litigation

Cantor Colburn has substantial experience representing clients in Hatch-Waxman and related pharmaceutical litigation matters. We focus on defending the rights of both drug discovery companies seeking to protect and enforce their patent rights, as well as defending generic pharmaceutical companies against allegations of patent infringement, including arising out of ANDA filings. Cantor Colburn counsels its pharmaceutical clients even before suit is filed, providing guidance during the preparation of ANDAs, performing opinion work, and preparing Paragraph IV letters.

By taking the time to understand the intricacies and nuances of the science, Cantor Colburn works with its pharmaceutical clients to develop litigation strategies that complement business objectives. As one of the nation’s leading full-service IP firms, Cantor Colburn combines an unparalleled depth of technical talent with highly experienced trial lawyers to form one of the most effective Hatch Waxman litigation teams in the country.

Our approach to pharmaceutical litigation – as with any disputed matter that we handle – is to work collaboratively with our client to understand its short and long term business goals. By fully understanding our clients’ business objectives, we are able to craft litigation strategies that lead to efficient and successful case outcomes.

Members of our Pharmaceutical Litigation Team have successfully represented parties nationwide in: